Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile Article

Wilson, Kenneth J, Xiao, Jingbo, Chen, Catherine Z et al. (2018). Optimization of the first small-molecule relaxin/insulin-like family peptide receptor (RXFP1) agonists: Activation results in an antifibrotic gene expression profile . EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 156 79-92. 10.1016/j.ejmech.2018.06.008

Open Access

cited authors

  • Wilson, Kenneth J; Xiao, Jingbo; Chen, Catherine Z; Huang, Zaohua; Agoulnik, Irina U; Ferrer, Marc; Southall, Noel; Hu, Xin; Zheng, Wei; Xu, Xin; Wang, Amy; Myhr, Courtney; Barnaeva, Elena; George, Emmett R; Agoulnik, Alexander I; Marugan, Juan J

sustainable development goals

authors

publication date

  • August 5, 2018

webpage

published in

keywords

  • 2-Acetamido-N-Phenylbenzamide
  • Antifibrotic
  • CELLS
  • Chemistry, Medicinal
  • G-protein coupled receptor
  • HORMONE
  • Life Sciences & Biomedicine
  • MULTIPLE SIGNALING PATHWAYS
  • PREGNANCY
  • Pharmacology & Pharmacy
  • RELAXIN RECEPTORS
  • Relaxin
  • SERELAXIN
  • Science & Technology
  • TARGETS

Digital Object Identifier (DOI)

publisher

  • ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER

start page

  • 79

end page

  • 92

volume

  • 156